Biotech Values

[dewophile]

On the CC, management acknowledged that the actual Jeuveau price charged to injectors will be a discount to Botox with the size of the discount depending on the injector’s volume

I didn't get that from the transcript. In fact in my post in response to a question they admitted it would be priced w parity to botox after discounting (obviously individual practices may see a discount to botox based on volume but net net parity visa vie botox)
doesn't matter - the key is they are not racing to the bottom here for market share in terms of pricing which is good for all the players